Gregory Fraser
Stock Analyst at Truist Securities
(3.38)
# 974
Out of 4,711 analysts
34
Total ratings
53.85%
Success rate
17.19%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $60 → $62 | $53.35 | +16.21% | 8 | Oct 22, 2024 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $7.47 | -6.29% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $10 → $8 | $0.40 | +1,884.62% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $6.10 | +47.54% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $7.78 | -10.03% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $51.40 | -43.58% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $30.80 | +208.44% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $10.89 | +65.29% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $14.99 | +166.84% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 22, 2024
Maintains: Hold
Price Target: $60 → $62
Current: $53.35
Upside: +16.21%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $7.47
Upside: -6.29%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.40
Upside: +1,884.62%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $6.10
Upside: +47.54%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $7.78
Upside: -10.03%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $51.40
Upside: -43.58%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $30.80
Upside: +208.44%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $10.89
Upside: +65.29%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $14.99
Upside: +166.84%